Stocks Rated
SHOWING 2 OF 2
ATYR aTyr Pharma, Inc. Neutral ▼ DOWNGRADE Sep 15, 2025
INMB INmune Bio, Inc. Buy ▲ UPGRADE Mar 11, 2026SHOWING 1–2 OF 2 STOCKS RATED
1
Stock Taper ← Back to Analysts 
RATING FIRM
LUCID CAPITAL MARKETS
2 ratings across 2 stocks
RATING MIX
ACROSS THE 2 SHOWN
BUY 1
HOLD 1
SELL 0
LAST ACTION
Maintain 0
Upgrade 1
Downgrade 1
ATYR aTyr Pharma, Inc. Neutral ▼ DOWNGRADE Sep 15, 2025 INMB INmune Bio, Inc. Buy ▲ UPGRADE Mar 11, 2026